A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer

A. H. Ko, M. A. Tempero, Y. S. Shan, W. C. Su, Y. L. Lin, E. Dito, A. Ong, Y. W. Wang, C. G. Yeh, L. T. Chen

Research output: Contribution to journalArticlepeer-review

127 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences